PharmExtracta SpA
Marco Resciniti is an experienced professional in business development and sales within the pharmaceutical and healthcare sectors. Currently holding positions at PharmExtracta SpA and Phyllon GmbH, Marco Resciniti specializes in international markets development and sales management. With a technical sales background at PHARMATRANS SANAQ AG, Marco Resciniti focuses on innovative ingredients for solid oral dosage forms. A successful senior business consultant since 2012, Marco Resciniti has collaborated with various companies in management, marketing, and business strategy across diverse therapeutic areas. Educational credentials include an MBA in Healthcare and Leadership Management and an Executive MBA in Healthcare Management and Leadership, complemented by a PhD in Pharmacy and Pharmaceutical Technology.
This person is not in any teams
This person is not in any offices
PharmExtracta SpA
PharmExtracta SpA is the Italian company dedicated for more than 30 years to the development of phytotherapeutic and probiotic (intestinal and nonintestinal) therapeutic solutions for the gastroenterological, pediatric, gynecological and metabolic areas. PharmExtracta SpA which makes its R&D department the flagship, has developed 39 patents between raw materials and finished products, which has integrated its therapeutic solutions whose efficacy and safety is validated by 168 scientific publications in journals and high impact factor and 4 international reviews. The guarantee of a clinical result represents a daily challenge that PharmExtracta SpA transforms into an opportunity.